Panic Induction with Cholecystokinin-Tetrapeptide (CCK-4) Increases Plasma Concentrations of the Neuroactive Steroid 3α, 5α Tetrahydrodeoxycorticosterone (3α, 5α-THDOC) in Healthy Volunteers

This publication has 21 references indexed in Scilit:

• Neuroactive steroids are not affected by panic induction with 50 μg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers
  Journal of Psychiatric Research, 2004
• Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?
  Trends in Pharmacological Sciences, 2003
• Anxiolytic activity of an endogenous adrenal steroid
  Published by Elsevier ,2003
• Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study
  Neuropsychopharmacology, 2002
• GABA_A Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment
  American Journal of Psychiatry, 2002
• Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression
  Journal of Psychiatric Research, 2000
• Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events.
  Journal of Clinical Investigation, 1997
• Stress-induced increase in brain neuroactive steroids: Antagonism by abecarnil
  Pharmacology Biochemistry and Behavior, 1996
• Neurosteroids and GABAA receptor function
  Trends in Pharmacological Sciences, 1995
• Measurement of lactate-induced panic and anxiety
  Psychiatry Research, 1987